GlaxoSmithKline, the manufacturer of Paxil, has reportedly agreed to settle some 800 Paxil birth defect lawsuits for the sum of $1 billion. The Paxil settlements will pay individual families approximately $1.2 million.
The remaining 100 Paxil lawsuits include three that are set for trial later this year in Philadelphia.
Paxil is a controversial anti-depressant drug that has been linked to birth defects in pregnant mothers who were taking the drug. Such birth defects include cardiac problems and pulmonary hypertension.
- Colorectal Cancer Screening - November 6, 2020
- Factors Impacting Maternal Health During Hospital Births - August 1, 2019
- New Hampshire Should Adopt a Safe Patient Ratio Statute - June 5, 2018